Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S C Rice

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Nature Clinical Practice. Neurology|November 19, 2008
Should cannabinoids be used as analgesics for neuropathic pain?Andrew S C Rice
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Current treatment options in neuropathic painKathleen Hempenstall, Andrew S C Rice
The New England Journal of Medicine|October 16, 2014
Clinical practice. Postherpetic neuralgiaRobert W Johnson, Andrew S C Rice
Pain|October 22, 2020
An introduction to the Biennial Review of PainAndrew S C Rice, Francis J Keefe
Pain|December 13, 2006
Pain following herpes zoster: the influence of changing population characteristics and medical developmentsRobert W Johnson, Andrew S C Rice
Anesthesia and Analgesia|November 16, 2022
Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity Is Doing the Same Thing Over and Over and Expecting Different ResultsJames C Eisenach, Andrew S C Rice
Annual Review of Medicine|January 18, 2006
New treatments for neuropathic painAndrew S C Rice, Raymond G Hill
Pain|June 1, 1994
Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral painAndrew S C Rice, Stephen B McMahon
British Journal of Anaesthesia|June 9, 2019
Progress in pain medicine: where are we now?Lesley A Colvin, Andrew S C Rice
Anesthesiology|November 26, 2003
A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesiaW Paul Farquhar-Smith, Andrew S C Rice
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Nature Clinical Practice. Neurology|November 19, 2008
Should cannabinoids be used as analgesics for neuropathic pain?Andrew S C Rice
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Current treatment options in neuropathic painKathleen Hempenstall, Andrew S C Rice
The New England Journal of Medicine|October 16, 2014
Clinical practice. Postherpetic neuralgiaRobert W Johnson, Andrew S C Rice
Pain|October 22, 2020
An introduction to the Biennial Review of PainAndrew S C Rice, Francis J Keefe
Pain|December 13, 2006
Pain following herpes zoster: the influence of changing population characteristics and medical developmentsRobert W Johnson, Andrew S C Rice
Anesthesia and Analgesia|November 16, 2022
Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity Is Doing the Same Thing Over and Over and Expecting Different ResultsJames C Eisenach, Andrew S C Rice
Annual Review of Medicine|January 18, 2006
New treatments for neuropathic painAndrew S C Rice, Raymond G Hill
Pain|June 1, 1994
Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral painAndrew S C Rice, Stephen B McMahon
British Journal of Anaesthesia|June 9, 2019
Progress in pain medicine: where are we now?Lesley A Colvin, Andrew S C Rice
Anesthesiology|November 26, 2003
A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesiaW Paul Farquhar-Smith, Andrew S C Rice
Pageof 20